Therapeutic shoes for patients with diabetes — Certificate of Medical Necessity
This Certificate of Medical Necessity (CMN) documents clinical indications and certification requirements for therapeutic shoes/extra-depth or custom-molded shoes for patients with diabetes and is intended for providers certifying medical necessity.
No material clinical or coverage changes in this revision.
Coverage and Medical Necessity Criteria
Medical necessity criteria
Covered when ALL of the following are documented on the CMN and supporting office note:
All items must be documented on the CMN and supported by the typed office note as indicated on the form.
The CMN form does not list any explicit exclusions. The form is structured to document qualifying indications and physician attestation rather than to enumerate conditions that would automatically preclude coverage.
Coverage depends on documentation of diabetes and one or more qualifying conditions, completion and signature of the certifying physician on the CMN, and a supporting typed office note. Therefore, absence of a documented diagnosis of diabetes mellitus, failure to identify at least one listed qualifying condition (for example: prior amputation, previous ulceration, pre‑ulcerative callus, peripheral neuropathy with callus, foot deformity, poor circulation, hemiplegia/hemiparesis, or foot drop), a missing or unsigned physician signature on the CMN, or lack of evidence that the patient is under a comprehensive diabetes plan of care may render the request unsupported and subject to denial.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.